CPT2 and hepatocellular carcinoma: Moreover, HCC cells knocked down for CPT2 acquired resistance to lipotoxicity cell death by inhibiting FAO and Src-mediated c-jun NH-2-terminal kinase (JNK) activation [109,110,111,112].